APGE
NASDAQ · Biotechnology
Apogee Therapeutics Inc
$134.84
+0.35 (+0.26%)
Analyst Consensus
Hold
21
Analysts
High
Coverage
Price Target
Analyst Price Target
-24.7% upside
Low Target
$78.76
Average Target
$101.57
High Target
$153.22
Current Price
$134.84
Current
$134.84
$134.84
Target
$101.57
$101.57
$78.76
$101.57 avg
$153.22
Scenario Analysis
Bear Case
$78.76
-41.6%
Low target
Base Case
$101.57
-24.7%
Avg target
Bull Case
$153.22
+13.6%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$134.58
0.2% from high
52-Week Low
$34.34
+292.7% from low
50-Day SMA
$73.88
+82.5% vs SMA
200-Day SMA
$52.13
+158.7% vs SMA
RSI (14)
48.1
Neutral
Target vs 52W High
$101.57
-24.5% vs high
Next Earnings Report
Aug 10, 2026
Today
EPS Est: $-1.09
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |